Ultralife Corporation
ULBI · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $114 | $149 | $89 | $124 |
| - Cash | $9 | $11 | $9 | $7 |
| + Debt | $4 | $55 | $54 | $54 |
| Enterprise Value | $108 | $193 | $134 | $171 |
| Revenue | $43 | $49 | $51 | $44 |
| % Growth | -10.7% | -4.3% | 15.7% | – |
| Gross Profit | $10 | $12 | $13 | $11 |
| % Margin | 22.2% | 23.9% | 25.1% | 24.2% |
| EBITDA | $1 | $4 | $5 | $3 |
| % Margin | 1.5% | 7.3% | 9.5% | 5.7% |
| Net Income | -$1 | $1 | $2 | $0 |
| % Margin | -2.8% | 1.8% | 3.7% | 0.4% |
| EPS Diluted | -0.073 | 0.053 | 0.11 | 0.012 |
| % Growth | -238.8% | -52% | 848.3% | – |
| Operating Cash Flow | $0 | $6 | $3 | $3 |
| Capital Expenditures | -$1 | -$1 | -$1 | -$1 |
| Free Cash Flow | -$1 | $5 | $2 | $2 |